| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics, Inc. | Chief Operating Officer | Common Stock | 108,191 | $243,105 | $2.25 | 21 Nov 2022 | Direct |
| Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 157,600 | 18 Mar 2025 | Direct | ||
| Galera Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 135,000 | 25 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 18 Mar 2025 | 1 | $0 | 4 | Director | 20 Mar 2025, 16:10 |
| ABUS | Arbutus Biopharma Corp | 24 Feb 2025 | 0 | $0 | 3 | Director | 06 Mar 2025, 16:10 |
| GRTX | Galera Therapeutics, Inc. | 25 Feb 2023 | 1 | $0 | 4 | Chief Operating Officer | 28 Feb 2023, 18:06 |
| GRTX | Galera Therapeutics, Inc. | 21 Nov 2022 | 2 | +$10,700 | 4 | Chief Operating Officer | 22 Nov 2022, 15:05 |
| GRTX | Galera Therapeutics, Inc. | 12 Sep 2022 | 2 | +$10,700 | 4 | Chief Operating Officer | 13 Sep 2022, 16:10 |
| GRTX | Galera Therapeutics, Inc. | 28 Feb 2022 | 1 | $0 | 4 | Chief Operating Officer | 02 Mar 2022, 15:06 |
| GRTX | Galera Therapeutics, Inc. | 17 Dec 2021 | 2 | +$21,400 | 4 | Chief Operating Officer | 20 Dec 2021, 17:30 |